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a  b  s  t  r  a  c  t
Ebola hemorrhagic fever, caused by the highly virulent RNA virus of the ﬁloviridae family, has
become one of the world’s most feared pathogens. The virus induces acute fever and death,
often associated with hemorrhagic symptoms in up to 90% of infected patients. The known
sub-types of the virus are Zaire, Sudan, Taï Forest, Bundibugyo and Reston Ebola viruses. In the
past,  outbreaks were limited to the East and Central African tropical belt with the exception
of  Ebola Reston outbreaks that occurred in animal facilities in the Philippines, USA and
Italy. The on-going outbreak in West Africa that is causing numerous deaths and severe
socio-economic challenges has resulted in widespread anxiety globally. This panic may be
attributed to the intense media interest, the rapid spread of the virus to other countries like
United States and Spain, and moreover, to the absence of an approved treatment or vaccine.
Informed by this widespread fear and anxiety, we analyzed the commonly used strategies
to  manage and control Ebola outbreaks and proposed new approaches that could improve
epidemic management and control during future outbreaks. We  based our recommenda-
tions on epidemic management practices employed during recent outbreaks in East, Central
and  West Africa, and synthesis of peer-reviewed publications as well as published “ﬁeld”
information from individuals and organizations recently involved in the management of
Ebola epidemics.
The current epidemic management approaches are largely “reactive”, with containment
efforts aimed at halting spread of existing outbreaks. We recommend that for better out-
comes, in addition to “reactive” interventions, “pre-emptive” strategies also need to be
instituted. We  conclude that emphasizing both “reactive” and “pre-emptive” strategies is
more  likely to lead to better epidemic preparedness and response at individual, commu-nity, institutional, and government levels, resulting in timely containment of future Ebola
outbreaks.∗ Corresponding author.
E-mail addresses: gmatua@gmail.com, gamandu@squ.edu.om (G.A.
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ntroduction
bola hemorrhagic fever (EHF) or Ebola virus disease (EVD) is
he human disease caused by infection of the single stranded
NA viruses of the genus ‘Ebola’ and family ‘Filoviridae’. Ebola
irus was discovered in 1976, following coinciding outbreaks
n Zaire, now Democratic Republic of the Congo (DRC), and
udan.1,2 EVD usually begins with an acute fever, causing
eath following hemorrhagic symptoms in up to 90% of cases
epending on the viral species.1,2 The known species include
undibugyo Ebolavirus (BEBOV), Sudan Ebolavirus (SEBOV), Zaïre
bolavirus (ZEBOV), Reston Ebolavirus (REBOV) and Côte D’Ivoire
bolavirus (CIEBOV), also known as, Taï Forest Ebolavirus (TAFV).
he REBOV strain has caused no human deaths so far, but has
een lethal to chimpanzees, gorillas and monkeys.3,4
In terms of pathogenicity, SEBOV strain leads to case fatal-
ty rates of 40–60%, ZEBOV rates range from 60% to 90%,
hile the BEBOV strain is associated with fatality rates of
5%. The CIEBOV subtype has been implicated in a single
on-fatal human case.2,4 Generally, this high fatality rate,
he international spread of the virus across borders, includ-
ng the possible use of the viral isolates as a possible tool
or bioterrorism make EVD an important public health con-
ern of global proportions. Consequently, Ebola outbreaks
ead to widespread fear, anguish and hysteria, locally and
nternationally, due to media attention, commerce, travel and
ourism.3,5
Typically, EVD leads to rapid suppression of the immune
ystem, triggering systemic inﬂammatory response causing
mpaired vascular, coagulation and immune systems func-
ioning, resulting in multiple organ failure, hypovolemic shock
nd death.2,5 Since its discovery in 1976, no effective vaccine
r post-exposure treatment exists to date. Hence, the cur-
ent disease management plan consists of supportive therapy
o revive infected patients, minimizing infection transmis-
ion, and calming anxious populations.2,3 These interventions
ften require interdisciplinary efforts instituted at both com-
unity and healthcare institutions.
In this paper, we discuss the epidemiology, clinical features
nd mode of transmission of Ebola virus. We also highlight
pidemic response efforts instituted in recent outbreaks in
ast, Central and West Africa. We  recommend strategies for
mproved epidemic management during and in-between out-
reaks. The paper is based on synthesis of original research
nd review papers indexed in MEDLINE, Scopus, PubMed,
INAHL, Science Direct, and Google Scholar databases, pub-
ished between January 2000 and September 2014, as well as
ata collected during a doctoral research study conducted in
ganda between June and July 2013.
To reﬂect current practices and highlight speciﬁc aspects
f epidemic management, we have also included substantial
mounts of recent “ﬁeld” information from individuals and
rganizations involved in the recent outbreaks, in the form
f online resources, newspaper articles, press releases and
linical guidelines. The resources and publications used were
btained from data bases using combinations of the Medi-
al Subject Headings (MeSH) and related search terms, “Ebola
emorrhagic fever”; “Ebola virus disease”; “ﬁloviridae infec-
ions”; “Ebola epidemics”; “communicable disease control”;5;1 9(3):308–313 309
“case management”; “disease surveillance”; “epidemiology”
and “disease management”. Peer-reviewed articles published
in the last decade in English that focused on Ebola and Marburg
was prioritized.
Focus  of  the  study
This article brieﬂy introduces the reader to Ebola virus disease,
the various strains and the common signs and symptoms of
the disease, including current epidemic management strate-
gies. The paper ends with recommendations for improved
epidemic management strategies based on the lessons learnt
from outbreaks in East, Central Africa and West Africa.
Mode  of  transmission
The exact transmission mode of Ebola viruses from their nat-
ural reservoir to humans or non-human primates remains
largely unknown,2,6 although most outbreaks appear to be
zoonotic. In laboratory animals, the virus can initiate infec-
tion following ingestion, inhalation or passage through breaks
in the skin.4,7 In non-human primates, experiments have also
shown that transmission can occur through droplet inocula-
tion of the viruses into the mouth or eyes.8
In humans, outbreaks usually occur following person-to-
person transmission involving direct contact with the mucous
membranes or broken skin with contaminated blood, vomitus,
urine, feces, and semen from infected persons.7,9 During out-
breaks, it has been shown that direct contact among humans
occurs during funerals, as part of ritual handling of corpses,
as a major mode of interfamilial transmission.8,10 In addition,
healthcare workers are at risk of infection if they care for
Ebola patients without appropriate protective measures due
to shortages and poor infrastructure or following exposure to
patients with unrecognized Ebola virus disease.5,11
Contrary to the belief that the Ebola virus is conﬁned to
the rain forest of Central Africa, the on-going outbreak in
West Africa3,11 has shown that the virus can spread rapidly
and widely, covering large areas, in this case Guinea, Liberia,
Sierra Leone, Nigeria, Senegal, Mali, and USA. The factors
implicated in this spread are fear, denial, misinformation, mis-
trust, concealment, and rumor. These resulted in contacts
and infected persons to avoid or escape from surveillance
systems or treatment centers,3,11 or relatives hiding symp-
tomatic family members or taking them to traditional healers.
Such unregulated movement  of infected persons across bor-
ders ampliﬁes Ebola epidemics, exacerbated by inadequate
surveillance systems and medical isolation centers,11,12 and
persistent high-risk cultural practices like consumption of
bush meat and funeral rituals where physical contact occurs
with the deceased patient.2,13
In addition to human to human contact, direct contact with
infected wild animals such as gorillas or chimpanzees dur-
ing hunting, butchering and while preparing meat has been
a signiﬁcant source of infection to humans especially in the
DRC, Gabon, and Uganda.2,13 Apart from contact with infected
non-human primates, human exposure to bat secretions or
excretions has also been demonstrated to be a potential route
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for acquisition of Marburg and Ebola viruses following studies
done in the DRC and Uganda.14 During epidemics, nosocomial
infection associated with medical procedures such as intra-
venous site insertions and surgeries have ampliﬁed ﬁlovirus
epidemics, especially where rules of universal precautions,
barrier nursing, and infection control are not well observed.5,9
These examples further demonstrate that transmission of
Ebola viruses can occur through contaminated patient care
equipment and supplies. Ebola virus has also been transmitted
following accidental infection of workers in Biosafety-Level-4
(BSL-4) facilities during investigational studies.15 These trans-
mission modes and observations in Uganda, the DRC, and
West Africa conﬁrm that large Ebola epidemics occur after
patients enter weak healthcare systems, where barrier nurs-
ing and epidemic management practices are inadequate due
to the lack of facilities.5,12,13
Clinical  manifestations
Infected patients present with severe headache, shivers, sore
throat, muscle aches, weakness and hiccups in the early
stages of the illness, following an incubation period of 2–21
days.6,16 As the disease progresses, patients develop nau-
sea, vomiting, difﬁcult breathing, abdominal pain, diarrhea,
pharyngitis, conjunctivitis, organ dysfunction, hypovolemic
shock, and bleeding from body oriﬁces and intravenous injec-
tion sites, eventually ending up in death.2,8 For survivors, the
process of recovery is very slow, characterized by complaints
of severe loss of weight, scaly skin, loss of appetite, sexual
weakness and inﬂammation of the testes in male survivors.
In addition, visual and hearing difﬁculties, tiredness, mental
stress, muscle and bone pains, including menstrual distur-
bances in female survivors, are also common.2,8,9
Strategies  for  effective  epidemic  management
and containment
The management of Ebola outbreaks continues to be com-
plicated by several challenges and shortcomings. These
difﬁculties relate to clinical management of patients, con-
tact tracing, disease surveillance, logistics, laboratory testing,
communication, resistance, panic and hysteria in affected
populations. This is further complicated by the fact that the
natural reservoir of the virus remains unknown,2,6 thereby
negatively impacting primary prevention.
In absence of primary prevention, epidemic management
focuses mainly on educating the masses and instituting sec-
ondary strategies during outbreaks and in the aftermath.
The success of secondary prevention strategies requires good
understanding of the public’s views about Ebola as a dis-
ease. Understanding people’s views and perspectives helps
health workers, government ofﬁcials and development part-
ners to design effective approaches to educate the masses
about Ebola and its effects, including how to deal with its social
consequences.9,17,18The learnt lessons from previous outbreaks indicate that
incorporating community’s perspectives and beliefs helps in
gaining their support and to demystify the epidemic, result-
ing in reduced fear, panic and antisocial sentiments during 1 5;1  9(3):308–313
an Ebola outbreak3,16,19 In fact, incorporating the perspectives
of local populations into national epidemic response efforts,
with support from international and local experts and local
and international partners, leads to better epidemic control,
particularly in resource challenged environments.11,17,19
Currently, the most dominant outbreak management strat-
egy may be classiﬁed as “post outbreak interventions”. However,
the continuing outbreaks in East, Central and West Africa
demonstrates the urgent need for health workers, interna-
tional agencies, development partners and governments to
institute not only the usual “post outbreak interventions”, but to
also emphasize additional response strategies, which we  refer
here as “constant interventions”. This strategy permits dealing
with the reality and threat of Ebola decisively and effectively.
“Post outbreak interventions” are “reactive” actions under-
taken at community or institutional levels to mitigate the
spread of on-going epidemics, while “constant interventions” are
“pre-emptive” steps taken at individual, community and insti-
tutional levels to boost preparedness and readiness to deal
with future epidemics. “Constant interventions” can help to sig-
niﬁcantly boost health workers’ understanding of the human
aspects of the illness, by illuminating hidden aspects of what
the illness means to the locals and how their notions about
Ebola blend with cultural beliefs and practices and how these
impact epidemic responses in the future.20
Post  outbreak  interventions
Post outbreak interventions are “preventive and corrective
measures” instituted by epidemic response teams once an
outbreak has begun. It aims to prevent further spread of infec-
tion, and encourage individuals and communities to engage
in activities that can slow and halt the spread of the virus.21
The interventions vary widely from basic hygienic practices
such as hand washing and cleaning of clothing and hunting
tools to proper cooking of meals especially of meat products,
all to minimize contamination. The strategy also empha-
sizes timely case management as well as mobilization of
communities in at-risk areas against consumption of bush
meat, including wild hoofed animals, primates, rodents and
bats.6,11,21
Post outbreak interventions further encourages timely
identiﬁcation of probable patients, transferring suspects
to designated medical facilities, monitoring suspects and
enforcing infection control measures in health facilities and
communities. When properly implemented, this strategy con-
siderably slows down epidemics, eventually leading to its
mitigation.2,10,17 In recent outbreaks in East, Central and West
Africa, the post outbreak interventions used may be classi-
ﬁed under active disease surveillance, laboratory conﬁrmation, case
management, social mobilization, education and training, resource
mobilization as well as communication.
The practice of ‘active disease surveillance’ encourages
healthcare practitioners working in urban and rural commu-
nities and hospitals to document, report, and promptly refer
contacts to isolation centers, ensuring swift detection and
control of new infections. This case-by-case reporting of ‘sus-
pects’ to national or regional Ebola response teams allows their
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rompt follow-up and referral to isolation centers, as well as
o assess the scope of the epidemic.2,20
The intervention of ‘laboratory conﬁrmation’ is mandatory
hen an epidemic is suspected, up to the point where the epi-
emic is conﬁrmed and then diagnosis can be based on clinical
anifestations.8–10 Setting up a ﬁeld-screening laboratory to
andle samples safely, securely and timely is mandatory to
acilitate prompt diagnosis and to guide mode of patient
are.10,18
The mode of ‘case management’ depends on whether the
atient belongs to the surveillance categories of “alert”, “sus-
ect”, “probable” or “conﬁrmed”; which ranges from suspected
ontact with an infected person to laboratory conﬁrmation of
bola infection. When a person is declared “conﬁrmed” case,
hey are immediately isolated, followed by speedy initiation of
upportive therapy.9,19 When the patient makes full recovery,
roper discharge is mandatory to ensure that there is unhin-
ered reintegration back into their home communities, which
ormally occurs due to fear and stigma following the hospital-
zation of Ebola patients and contacts.10,11 Case management
lso involves establishing safe burial practices,19,20 including
dentifying suitable burial grounds, training burial teams and
eveloping guidelines to ensure safe burial.22 Further, case
anagement entails ensuring that no direct contact occurs
ith the deceased and burials are restricted to trained teams
n full personal protective equipment.10,19
The steps of “social mobilization” are employed to facili-
ate multisectoral collaboration, epidemic preparedness and
esponse because of the ability to inﬂuence both health
orkers and community members to actively participate
n epidemic control.18,23,24 The media has been used for
ocial mobilization, especially local radio stations to educate
ommunities for rapid and meaningful response in affected
reas.9,10 Social mobilization has also incorporated the use
f community drama groups at public places such as mar-
ets, schools and worship places to attract mass attention and
hen to pass key messages to win  peoples’ conﬁdence, includ-
ng ﬁghting social stigma.20 Documentary ﬁlms and educative
osters have been used to discourage “high-risk” practices,
uch as handshakes, large gatherings, healing practices and
raditional burial rituals to curtail rates of infection and pro-
ote epidemic response.10,22,24
Educating and training healthcare practitioners and
ommunity resource persons during outbreaks has been
nother major intervention employed to prepare communi-
ies to participate in surveillance and epidemic management
ctivities.19,22 This intervention is vital because correct man-
gement of epidemic control activities leads to appropriate
ommunity response.10,22,25 Besides providing information
bout epidemic response, “personal safety training”, is also
mphasized with special focus on safe wearing and removal of
ull-body equipment. The training also emphasizes the “buddy
ystem” of working in pairs, where colleagues watch over each
ther, when wearing protective gears and when providing
atient care to ensure no steps are missed and their safety is
uaranteed.21,22,26 The education and training sessions ensure
hat there is both knowledge and readiness to respond to on-
oing epidemics.
Resource mobilization after an outbreak is vital because
he ﬁght against Ebola epidemics is highly resource intensive.5;1 9(3):308–313 311
This may be in form of medical and support staff, ﬁnances,
vehicles, food, clothing, personal items or as hospital and
laboratory equipment and supplies.8,9,27 To succeed in
resource mobilization, there is need for multisectoral collab-
oration between ordinary citizens, civil society organizations,
political and faith based organizations, as well as local
and international development partners and government
departments.10,27,28
Another vital aspect of epidemic control that signiﬁcantly
affects the outcome of outbreak management is the commu-
nication strategy. Field experiences from previous outbreaks
indicate that epidemic related information should be commu-
nicated to the public in ways that build, maintain or restore
trust and respect local cultures and country norms.29,30 Infor-
mation sharing between stakeholders, such as government
departments, development partners, religious bodies, training
institutions, local leaders and the public leads to timely inter-
ventions. Improved communication is thus critical because
it facilitates resource identiﬁcation and mobilization, social
mobilization, education and training, surveillance and case
management as well as helping to re-integrate survivors and
contacts into families.19,27,28
A key element of improved communication is early integra-
tion and involvement of the media to help with shaping the
public’s perception about the epidemic and to educate them on
disease prevention and control mechanisms.18,27,28 Improved
communication also necessities obliging media agencies, both
local and international media outlets, to communicate, to the
public in a timely manner, vital epidemic information in ways
that instil conﬁdence and not fear, encouraging and mobiliz-
ing key stakeholders in the community, country and globally to
respond to any health threats, including actively contributing
to outbreak management.18,30,31
Early involvement of the media was noted to result in more
accurate and timely reporting,16,18,19 creating awareness for
infection prevention. This in turn prompts community action
including rushing suspected cases to isolation centers.10,19
This increased awareness also encourages individuals to avoid
contact with ‘suspect’ cases and inspires better compliance
with and support for epidemic control guidelines leading to
mitigation of the epidemic.19,27,31
Constant  interventions
In addition to the reactive, ‘post outbreak interventions’, that
characterizes current epidemic management, we propose that
the continued sporadic occurrence of Ebola epidemics in East,
Central and West Africa requires a more  holistic way to deal
with the threat of the epidemic. We suggest a strategy con-
sisting of “pre-emptive” steps, termed, ‘constant interventions’
approach, that should be undertaken at individual, commu-
nity and institutional levels following an epidemic and to be
continued in the aftermath, that is in-between the outbreaks.
Emphasizing such “pre-emptive” strategy is likely to
improve the epidemic readiness, particularly that of “at-risk”
populations and government agencies in ‘high-risk’ countries.
When properly implemented, such holistic measures help to
enhance the knowledge related to Ebola outbreaks, as well
as preparedness and readiness of populations, healthcare
i s . 2 0
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institutions and key government departments to respond in
a timely manner should an epidemic emerge.
In essence, ‘constant interventions’ are intended to keep
populations and institutions in ‘high-risk’ areas ready, fully
prepared and constantly aware of the risk of Ebola outbreak
recurrence. Such preparedness is likely to result in rapid
epidemic response should an outbreak occur, considerably
enhancing the possibility of timely epidemic control. We  rec-
ommend that the “constant interventions” strategy employed
should be informed by the public’s perceptions and beliefs
about Ebola and should address any gaps that exist in their
understanding of the illness. This implies that interventions
carried out in-between outbreaks should be relevant and evi-
dence based,18,19 further maintaining that during “constant
interventions”, health teams should address misinformation,
rumors, beliefs, and peoples’ peculiar experiences with previ-
ous Ebola outbreaks. This is vital not only for “neutralizing”
negative perceptions about Ebola and its management, but
rather to help in conﬁdence building and motivating com-
munities to trust more  in the health care workers and the
outbreak related services.19,27,31
Preferably, these interventions should be implemented at
both individual and family (human or micro) and institutional
and governmental (macro) levels. This “binary” approach
has the capacity to enhance individuals’, families’, institu-
tions’ and countries’ epidemic preparedness and response
in the event of new outbreaks. The “constant interventions” at
individual/family (micro) level should focus largely on infor-
mation provision, sharing best practices and health education
to increase knowledge levels.19,31 In contrast, at govern-
mental/institutional (macro) level, the “constant interventions”
should seek to improve the capacity and readiness of various
departments that usually provide essential services required
to respond to outbreaks.
We  recommend that to enhance institutional effective-
ness, health practitioners in ‘at-risk’ areas and countries
need to be kept constantly up-to-date with current epidemic
response strategies, reinforced through regular seminars and
workshops.18 The “constant interventions” strategy ensures that
health institutions infrastructure are “epidemic ready”. This
readiness entails making signiﬁcant improvements in health
facility infrastructure such as improving isolation units, diag-
nostic laboratories and instituting infection control facilities
and procedures.10 Such interventions are particularly vital
in Ebola prone areas of East, Central and West Africa where
sporadic outbreaks have occurred.11,19 When properly imple-
mented, these “constant interventions” can ensure that health
workers, community leaders and the public are properly
informed about the true nature of Ebola including recom-
mendations for outbreak containment aimed at early case
detection, reporting and clinical management. These inter-
ventions also ensure that vital health and related service
institutions in at-risk communities and countries are fully
prepared and ready to respond to an imminent epidemic.Conclusions
Ebola virus disease is a serious public health concern because
of its frightening nature and the large number of deaths 1 5;1  9(3):308–313
associated with it, resulting from multi-organ and multi-
system failure and hypovolemic shock.2,6,9 Currently, no
globally approved treatment or vaccine exists. This lack
has contributed to the failure to control the on-going Ebola
outbreaks affecting large parts of West Africa, despite
efforts of a global coalition coordinated by the World Health
Organization.3,11 The scale of the outbreak has pressured
world players and the pharmaceutical players to speed up
the human trials of available candidate vaccines,3,32,33 and
necessitated the use of previously untested drugs on Ebola
patients,34 leading to unprecedented ethical challenges.35,36
In the absence of a recognized deﬁnitive vaccine and
treatment, the best option to deal with Ebola outbreaks is
designing more  responsive approaches to manage on-going
epidemics and to promote epidemic preparedness and readi-
ness among individuals, non-governmental organizations
and government departments in high-risk countries.2,18,19
In Ebola prone areas and particularly during outbreaks, it is
vitally important that health workers, international agencies,
development partners and governments establish epidemic
management strategies early and such efforts should continue
well into the aftermath of outbreaks. Incorporating both “post
outbreak interventions” and “constant interventions” offers a real
chance for health teams and governments to deal with the
threat of an on-going and future Ebola outbreaks in a timely
and decisively way. The advantage of this “binary” approach
is that while “post outbreak interventions” enhance communi-
ties and health care institutions’ capacity to mitigate further
spread of an on-going epidemic, the ‘constant interventions’ at
individual, community and institutional levels deepen their
understanding about Ebola, thereby enhancing overall epi-
demic preparedness and response.
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